Affiliation:
1. Core for Cell Technology, School of Medicine, Pontifícia Universidade Catolica do Parana, Curitiba, Brazil
Abstract
Background:
Mesenchymal Stromal Cells (MSC) have the potential for self-renewal
and differentiation in different tissues, characteristics that encourage their use in regenerative
medicine. Dental tissue MSCs are easy to collect, have the same embryonic origin as neurons and
have neuronal markers that allow their use in treating neurodegenerative diseases. Human Exfoliated
Deciduous teeth (SHED)-derived stromal cells are considered immature and present positive expression
of pluripotency and neuronal markers. Studies have shown that after the induction of neuronal
differentiation in vitro, SHED increased the expression of neuronal markers, such as βIIItubulin,
nestin, GFAP, NeuN, and NFM, demonstrating the potential use of these cells in preclinical
studies. The results of this review reflect the consensus that in diseases such as spinal cord injury,
cerebral ischaemia, and Alzheimer’s and Parkinson’s disease, SHED could function in the suppression
of the inflammatory response, neuroprotection, and neuronal replacement.
Conclusion:
For these cells to be used in large-scale clinical trials, standardization of the isolation
techniques and theneuronal induction medium are necessary. The potential of SHED to induce neuronal
differentiation is evident, demonstrating that this resource is promising and shows great potential
for use in future preclinical and clinical trials of neurodegenerative diseases.
Publisher
Bentham Science Publishers Ltd.
Subject
General Medicine,Medicine (miscellaneous)
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献